Science and technology

We are committed to providing innovative solutions to people with allergy using cutting-edge science

ALK has a long track record in breakthrough discoveries in allergy research. Working closely with physicians and academia including universities and research institutions has been a natural ingredient of our 100-year journey as a company. This has resulted in advancements in diagnostic solutions and continuous improvements in the safety and effectiveness of AIT vaccines and of allergy diagnosis and management globally.

New technologies

We are constantly exploring new emergent technologies evaluating their potential relevance for providing improved solutions for people with allergy.

One such example is applying allergen extracts daily under the tongue formulated in fast dissolving tablets. This approach was pioneered by ALK scientists and is now offered to millions of people with allergy at a global scale covering a broad range of major allergies.

Biomarkers and drug discovery

Through decades of clinical research and development we have generated new knowledge and insights from a comprehensive biobank of samples from people with allergy and people undergoing treatment with allergy immunotherapy.

We are committed to advancing the understanding of the allergic disease. This covers mechanistic research aimed at identifying potential biological pathways that may be targeted for therapeutic effect and biomarkers potentially optimising use of existing and future treatments.

Success through collaborations

We have always believed in the importance of open innovation and partnership models to advance innovation in allergy research. Excellence in science is one of our core ambitions and, we believe, required to improve the understanding of the allergic disease aiming at advancing patient care.

Working with academic partners, we have for decades been on the forefront of research within cellular and molecular pathways of the allergic inflammation, most recently exemplified by the discovery of the IgE memory B cell.

ALK and McMaster researchers discover new cell that remembers allergies | ALK.